Heart Failure Tech: Can New Devices Cut Your Healthcare Costs?

Lena Kashyap in Health & Wellness April 2025 • 3 min read.

"Innovative heart devices like MultiPoint Pacing (MPP) show promise in reducing hospital visits and saving you money. Is this the future of heart failure treatment?"

Heart failure is a serious condition, but technological advancements are offering new hope. MultiPoint Pacing (MPP) is one such innovation. This technology aims to improve cardiac resynchronization therapy (CRT), a treatment used to help the heart's chambers beat in a coordinated way.

Traditional CRT uses a quadripolar biventricular pacing (QUAD-BiV) system. MPP, however, offers a different approach by pacing from multiple points in the heart. Early studies suggest that MPP, particularly when configured for anatomically distant pacing (MPP-AS), may lead to better patient outcomes. This article explores whether MPP-AS can reduce healthcare costs associated with heart failure.

We'll delve into the findings of a study presented at the 22nd Annual Scientific Meeting of the Heart Failure Society of America (HFSA), which investigated the potential cost savings of MPP-AS compared to QUAD-BiV. The goal is to understand how these technologies impact hospitalization rates, emergency room visits, and overall healthcare expenses for heart failure patients.

MPP-AS: A Cost-Effective Solution for Heart Failure?

The study used a model to simulate the costs associated with both MPP-AS and QUAD-BiV over a 10-year period. Researchers looked at various factors, including:

The Future of Heart Failure Treatment Costs

While the study suggests that MPP-AS may offer cost savings compared to QUAD-BiV, it’s important to note that these findings are based on a simulation model. More research is needed to confirm these results in real-world clinical settings. However, the study highlights the potential for innovative technologies like MPP-AS to not only improve patient outcomes but also reduce the financial burden of heart failure.